Suzanne M.

Drug Safety
Health Services Research

144 College Street
Toronto ON M5S 3M2

Suzanne M. Cadarette, BSc (University of Waterloo), MSc and PhD (University of Toronto), PDF (Harvard University and Brigham and Women’s Hospital, Boston) is Associate Professor of Pharmacy, Graduate Coordinator in the Department of Pharmaceutical Sciences, Full Member with the School of Graduate Studies, University of Toronto; and Senior Adjunct Scientist, Institute for Clinical Evaluative Sciences.

Cadarette’s primary research interests are in pharmacoepidemiology, health services research and pharmacy practice, with focus in the areas of osteoporosis and fracture prevention.

Area of Research

Suzanne M. Cadarette, PhD is a pharmacoepidemiologist and health services researcher. Dr. Cadarette’s team (Cadarette Group) investigates the use, benefits and harms of prescription medications, and the use and impact of community pharmacy services.

Research Challenge

Valid estimates of the benefits and harms of drugs and health services in the “real-world” are required to inform prescribing and health policy decision making. Careful attention to detail is critical in the design and analysis of real-world studies, necessitating the integration of innovative analytical and study design methods.

Proposed Solution

The Cadarette Group leverages large healthcare administrative, pharmacy and medical claims databases to complete real-world studies that:

  1. inform practice clinical guideline development and health policy decision making, and
  2. guide the design and analysis of real-world studies.

Impact to Date

The Cadarette Group works directly with key stakeholders (e.g., Osteoporosis Canada) to inform clinical practice guidelines and policy decisions, and with international experts (e.g., International Society for Pharmacoepidemiology, STRengthening Analytical Thinking for Observational Studies (STRATOS) initiative) to improve the design and analysis of real-world studies.



Keywords: epidemiology, health policy, health services, fracture, innovation, pharmacoepidemiology, pharmacy practice, osteoporosis